Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2008
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Sodium cocoyl glycinate (SCG) [INCI]
IUPAC Name:
Sodium cocoyl glycinate (SCG) [INCI]
Details on test material:
- Physical state: Liquid
- Stability under test conditions: Stable in water for days at room temperature (not quantified)
- Storage condition of test material: At room temperature

Method

Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
induced rat liver S9-mix
Test concentrations with justification for top dose:
3, 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate / pre-experiment/experiment I and experiment II
Vehicle / solvent:
Deionised water
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
other: sodium azide; 4-nitro-o-phenylene-diamine; methyl methane sulfonate, 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar plate incorporation; preincubation


DURATION
- Preincubation period: 1 hour
- Exposure duration: 72 hours


NUMBER OF REPLICATIONS: 3 plates


Evaluation criteria:
A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed .
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration .
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Statistics:
According to the OECD guideline 471, a statistical analysis of the data is not mandatory.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS

Any other information on results incl. tables

Summary Tabellen

    Summary of Results Pre-Experiment and Experiment I

Study Name: 1211000

Study Code: Harlan CCR 1211000

Experiment: 1211000 VV Plate

Date Plated: 17/09/2008

Assay Conditions:

Date Counted: 24/09/2008

Metabolic

Activation

Test

Group

Dose Level

(µg/plate)

Revertant Colony Counts (Mean ±SD)

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

Without Activation

Deionised water

20 ± 3

11 ± 3

35 ± 2

137 ± 5

55 ± 4

Untreated

18 ± 3

13 ± 3

37 ± 10

126 ± 4

47 ± 3

Hostapon SG

3 µg

20 ± 3

11 ± 4

29 ± 1

134 ± 12

50 ± 4

10 µg

19 ± 4

14 ± 2

33 ± 5

124 ± 8

52 ± 6

33 µg

18 ± 3

11 ± 4

35 ± 6

132 ± 10

55 ± 1

100 µg

19 ± 4

8 ± 0

37 ± 6

139 ± 16

52 ± 4

333 µg

13 ± 2

10 ± 4

32 ± 8

122 ± 15

63 ± 3

1000 µg

17 ± 2

7 ± 1

25 ± 5

84 ± 11 R

62 ± 2

2500 µg

8 ± 2 M R

2 ± 2 M R

19 ± 2 M R

36 ± 5 M R

59 ± 2

5000 µg

2 ± 2 M R

0 ± 1 M R

5 ± 2 M R

27 ± 3 M R

58 ± 2

NaN3

10 µg

2009 ± 31

2369 ± 114

4-NOPD

10 µg

424 ± 9

4-NOPD

50 µg

83 ± 3

MMS

3.0 µL

1017 ± 33

With Activation

Deionised water

23 ± 3

20 ± 5

37 ± 4

148 ± 5

68 ± 4

Untreated

24 ± 6

19 ± 7

42 ± 8

148 ± 14

64 ± 9

Hostapon SG

3 µg

24 ± 3

19 ± 5

39 ± 5

129 ± 14

64 ± 4

10 µg

21 ± 5

17 ± 5

44 ± 8

135 ± 3

71 ± 2

33 µg

25 ± 3

19 ± 3

43 ± 6

132 ± 9

60 ± 11

100 µg

23 ± 1

15 ± 2

38 ± 4

134 ± 5

60 ± 4

333 µg

22 ± 5

13 ± 2

47 ± 6

136 ± 13

73 ± 11

1000 µg

15 ± 4

16 ± 3

35 ± 3

116 ± 13

69 ± 3

2500 µg

9 ± 3 M R

8 ± 1 M R

28 ± 2 M R

48 ± 7 M R

66 ± 1

5000 µg

5 ± 1 M R

1 ± 1 M R

13 ± 2 M R

34 ± 5 M R

59 ± 4

2-AA

2.5 µg

245 ± 16

191 ± 30

1267 ± 70

1506 ± 43

2-AA

10.0 µg

232 ± 24

Key to Positive Controls

Key to Plate Postfix Codes

NaN3

2-AA

4-NOPD

MMS

sodium azide

2-aminoanthracene

4-nitro-o-phenylene-diamine

methyl methane sulfonate

R

M

Reduced background growth

Manual count

     Summary of Results Experiment II

Study Name: 1211000

Study Code: Harlan CCR 1211000

Experiment: 1211000 HV2 Pre

Date Plated: 01/10/2008 / 14/10/2008*

Assay Conditions:

Date Counted: 08/10/2008 / 17/10/2008*

Metabolic

Activation

Test

Group

Dose Level

(µg/plate)

Revertant Colony Counts (Mean ±SD)

TA 1535

TA 1537

TA 98*

TA 100

WP2 uvrA

Without Activation

Deionised water

19 ± 6

12 ± 4

22 ± 2

131 ± 5

51 ± 8

Untreated

16 ± 6

10 ± 2

24 ± 4

137 ± 12

46 ± 8

Hostapon SG

3 µg

17 ± 4

14 ± 5

23 ± 2

131 ± 8

55 ± 1

10 µg

18 ± 4

15 ± 2

24 ± 2

127 ± 9

52 ± 8

33 µg

18 ± 3

11 ± 6

24 ± 4

122 ± 1

55 ± 6

100 µg

22 ± 6

14 ± 3

23 ± 1

101 ± 15 R

56 ± 2

333 µg

12 ± 5

10 ± 4

15 ± 2

75 ± 7 R

47 ± 4

1000 µg

5 ± 2 R M

2 ± 3 M R

10 ± 1 M R

39 ± 5 M R

49 ± 5

2500 µg

2 ± 2 M R

0 ± 0 M R

3 ± 2 M R

31 ± 10 M R

46 ± 5

5000 µg

1 ± 1 M R

0 ± 0 M R

0 ± 0 M R

5 ± 2 M R

37 ± 7

NaN3

10 µg

1799 ± 67

1998 ± 31

4-NOPD

10 µg

1637 ± 116

4-NOPD

50 µg

105 ± 5

MMS

3.0 µL

418 ± 20

With Activation

Deionised water

17 ± 4

16 ± 5

26 ± 3

138 ± 9

58 ± 5

Untreated

18 ± 4

19 ± 7

29 ± 3

142 ± 37

64 ± 7

Hostapon SG

3 µg

19 ± 4

17 ± 4

27 ± 0

131 ± 11

59 ± 3

10 µg

22 ± 4

17 ± 4

25 ± 2

132 ± 8

58 ± 3

33 µg

20 ± 2

19 ± 3

24 ± 2

141 ± 15

59 ± 6

100 µg

21 ± 1

15 ± 3

22 ± 5

140 ± 7

57 ± 5

333 µg

18 ± 4

14 ± 4

19 ± 3

110 ± 5 R

53 ± 2

1000 µg

11 ± 3 M R

12 ± 2 M R

10 ± 2 M R

74 ± 7 R

54 ± 1

2500 µg

9 ± 3 M R

8 ± 2 M R

4 ± 3 M R

31 ± 2 M R

59 ± 4

5000 µg

0 ± 0 M R

0 ± 0 M R

0 ± 0 M R

31 ± 4 M R

61 ± 3

2-AA

2.5 µg

256 ± 8

105 ± 10

1616 ± 151

1346 ± 157

2-AA

10.0 µg

334 ± 24

Key to Positive Controls

Key to Plate Postfix Codes

NaN3

2-AA

4-NOPD

MMS

sodium azide

2-aminoanthracene

4-nitro-o-phenylene-diamine

methyl methane sulfonate

R

M

Reduced background growth

Manual count

* Repeated experiment

Applicant's summary and conclusion

Conclusions:
The registration substance Hostapon SG is not mutagenic in Ames test.
Executive summary:

The registration substance Hostapon SG was investigated for its mutagenicity in bacterial mutation reverse assay according to the Guideline OECD 471. Up to the concentration of 5000 µg/plate no mutagenic property was found without and with metabolic activation in strains TA 1535, TA 1537, TA 98, TA 100, WP2 uvrA in two indepedant experiments. Hostapon SG is not mutagenic in Ames test.